TP53 and osteosarcoma: Similarly, both compounds blocked proliferation of the osteosarcoma HDM2-amplified SJSA-1 cell line with 56- and 58-fold selectivity, respectively, compared to a control p53-null osteosarcoma SAOS-2 cell line (Figure 1B).